About Medcan Australia


Medcan Australia’s mission is to provide reliable access to patient specific Medicinal Cannabis products. We believe Medicinal Cannabis is not simply a “one pill suits all” solution.  Individual patients have specific needs and requirements and we aim to provide a specific product range based on a patient’s specific set of circumstances. Founded with a single vision to provide Australian patients with a high quality, fair priced product, Medcan is positioned to be a front runner in the Australia Medicinal Cannabis Industry.

With a vertically integrated model Medcan Australia will Cultivate, Produce and Manufacture high quality medicinal cannabis products for both clinical trials and individual patient access.  Our automated cultivation processes are designed to ensure consistent results so consumers are assured the quality, composition and reliability of their supply


Medcan Australia was granted the 13th Cultivation and Production licence from the Office of Drug Control in November 2017 with a nominated commencement start date for production  being the 1st of July 2018. Medcan was granted the ODC Medical Cannabis Manufacture Licence.

Medcan currently holds the following Office of Drug Control (ODC), Federal & State licenses making it one of few companies that can Cultivate, Produce and Manufacture Medicinal Cannabis Products:

o ODC Medical Cannabis Cultivation and Production Licence
o ODC Import Licence
o ODC Medical Cannabis Manufacture Licence
o ODC Export Licence
o DAWR (Department of Agriculture and Water Resources) Permit
o QLD Health Licence – Schedule 9 Substances

Medcan Australia’s facility with has the ability to produce up to 6,500kgs of dried cannabis per year.


Medicinal cannabis products are not registered medicines in Australia, so they must be accessed through special pathways available for unapproved medicines. Individual consumers cannot apply to TGA to obtain approval to access unapproved medicinal cannabis products. Such access can only be arranged through an Australian-registered medical practitioner with appropriate qualifications and/or expertise for the medical condition requiring treatment. This doctor can notify/apply on the patient’s behalf for approval to import and supply these products through the Special Access Scheme (SAS Category A or B). Alternatively, the doctor can apply to us to become an Authorised Prescriber (AP).  Approval or authorisation is granted on a case-by-case basis.

This doctor must also apply and obtain approval under the applicable state or territory laws to prescribe a medicinal cannabis product to a particular patient, where relevant. Rules relating to medicinal cannabis products vary between states and territories and could affect whether or not you can be prescribed particular medicines in your state or territory.  If both state and TGA requirements are satisfied then the pharmacy or hospital that the doctor has arranged to supply the product can dispense it.

We understand the patient licensing application can be daunting.  Having worked closely with both the ODC (Office of Drug Control) and the TGA (Therapeutic Goods Administration) we are very familiar with the licensing process.

MedCan Australia Products

Medcan Australia is building a diverse portfolio of medicinal cannabis genetics for its cultivation, distribution, and patient operations. As part of Medcan’s program of excellence, the company is seeking unique, premium quality cannabis products for importation and distribution across Oceana’s legal markets.